Navigation Links
Institut Pasteur Korea and Sanofi open a new research collaboration to combat HBV
Date:11/2/2011

will facilitate the discovery of drugs based on novel mechanisms to combat HBV, which is responsible for 38% of all cancer deaths in Korea".

Currently, most available HBV drugs inhibit reverse transcription, the process by which the virus RNA is transcribed into DNA for replication. However, new therapies are needed to compensate for the emerging resistance of the virus to these drugs. In contrast to the existing approaches, the IP-K screening effort focuses on compounds that interfere with the assembly of the HBV capsid, the outer shell of the virus. This approach is aimed at preventing the release of infectious virus particles into the bloodstream, thereby reducing the viral load in patients.

The leaders of the collaborating organizations share enthusiasm for the project. "We are excited to pave the way for connecting an excellent research output of Yonsei University to Sanofi, a global healthcare leader. This is a sophisticated approach that will accelerate the discovery of drugs to combat HBV," explains Dr. Ulf Nehrbass, CEO of IP-K. "It reduces cost, opens the door to entirely new classes of drugs, and offers new insights into the mechanisms of disease." Dr. Jae Eun Kim, the team leader at Sanofi also expects successful research achievements, and said, "This project will be a great opportunity to open a new era in HBV treatment.

Under the terms of condition, Sanofi will fund the initial phase of the project that is anticipated to last for one year, from which IP-K and Sanofi staff will jointly determine which compounds should be brought forward for optimization and further development. It is, "one of the foremost projects on HBV drug development being undertaken today and the new therapy will significantly increase possibility for complete recovery from Hepatitis B when supplemented by the current treatments." adds Dr. Wang-Shik Ryu.

This R&D collaboration was made possible by the Global Alliance Project (GAP) framework, wh
'/>"/>

Contact: Jean Kim
babunn@ip-korea.org
82-318-018-8041
Institut Pasteur Korea
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Dr. Jennifer L. Howse elected to Institute of Medicine
2. La Jolla Institute joins Sanford Consortium for Regenerative Medicine
3. The 18th Annual Institute on Teaching and Mentoring
4. Cell biologist Chris A. Kaiser to lead NIHs National Institute of General Medical Sciences
5. Trudeau Institute announces its latest discovery in the fight against tuberculosis
6. UT professor elected to the Institute of Medicine of the National Academies
7. Barshop Institute, global team sequences DNA of naked mole rat
8. Roche licenses DNA sequencing technology from Biodesign Institute
9. UCSB awarded $15 million by Dow to establish collaborative institute for materials research and education
10. Virtual institutes to support the scientific collaborations of the future
11. La Jolla Institute discovers novel mechanism for preventing infection via bodys mucosal borders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... 2014) A team of researchers in ... into the brains of nonhuman primates and assessed ... months found that the hNSCs had differentiated into ... tumors. , The study will be published in ... but is currently freely available on-line as an ...
(Date:4/23/2014)... evidence of an interaction between prenatal smoking and ... children, especially in girls. , "The interesting issue ... smoking will have behavioral problems. Some might, ... Professor at Sam Houston State University, College of ... "One possible explanation for this is that ...
(Date:4/23/2014)... Climate fiction, or simply cli-fi, is a newly coined term ... global warming. New research from University of Copenhagen shows how ... to simulate the potential consequences of climate change and imagine ... than scientific data on changes in the atmosphere; it is ... by the books we read and the films we see. ...
Breaking Biology News(10 mins):Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3
... One of the challenges of gene therapy - a ... (DNA or RNA) - is to assure that this material ... a substantial amount along the way and without producing any ... the use of different types of vectors, molecules capable of ...
... shellfish safer to eat has been pioneered by scientists at ... Institute for Agri-Food and Land Use, not only ensures shellfish ... but is likely to revolutionise the global fishing industry. While ... takes up to two days, the new test slashes the ...
... Aware, Inc. (Nasdaq: AWRE ), a leading ... industries, today announced that on January 5, 2011 its Board ... S. Stafford, III to the Aware Board of Directors.   ... Director and will serve on the Board,s Nominating and Corporate ...
Cached Biology News:Nanodisk gene therapy 2Shellfish safer to eat thanks to breakthrough by Queen's scientists 2Aware Announces Appointment of New Directors 2Aware Announces Appointment of New Directors 3
(Date:1/15/2014)... , Jan. 15, 2014 ­ RedBrick Health , ... change technology, today announces that EmblemHealth , the ... wellness company, is now providing the RedBrick Compass health ... program, to all of its members. EmblemHealth is among ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Microcompetition with ... major disease. One of these latent viruses is the Epstein ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... a study found that RA patients have high concentrations of ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 As pet owners drew ... doubt many of them wrote: "Take better care of my furry ... even designer clothes and top-brand carrying cases to take the little ... parents might also feel compelled to buy some pricey toys at ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... done and now they,ve done it. What,s more, they did ... U.S. Department of Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley ... the first experimental demonstration of GRIN for gradient index ... a wide range of exotic optics, including superfast computers based ...
... 2011 Amgen (Nasdaq: AMGN ) and ... into a definitive acquisition agreement under which Amgen has ... venture-funded,  biotechnology company headquartered in Woburn, Mass. BioVex is ... Phase 3 clinical development, that may represent a new ...
... (Nasdaq: CEPH ) will hold a public memorial service ... and CEO on February 1, 2011, at 6:00 p.m. at The ... Dr. Baldino founded Cephalon in 1987 and led the ... ten biotechnology companies in the world. He was a recognized pioneer ...
Cached Biology Technology:GRIN plasmonics 2GRIN plasmonics 3GRIN plasmonics 4Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 2Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 3Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 4Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 5Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 6Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass 7Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D. 2